Eagle Pharmaceuticals
EGRX
#10505
Rank
HK$22.18 M
Marketcap
HK$1.71
Share price
46.67%
Change (1 day)
-63.28%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: HK$22.18 Million

As of December 2025 Eagle Pharmaceuticals has a market cap of HK$22.18 Million. This makes Eagle Pharmaceuticals the world's 10505th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$22.18 M-59.91%
2024HK$55.33 M-89.57%
2023HK$0.53 B-82.15%
2022HK$2.97 B-42.03%
2021HK$5.12 B9%
2020HK$4.70 B-26.24%
2019HK$6.37 B45.28%
2018HK$4.38 B-29.51%
2017HK$6.22 B-34.59%
2016HK$9.52 B-11.4%
2015HK$10.74 B536.79%
2014HK$1.68 B

End of Day market cap according to different sources

On Dec 19th, 2025 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
HK$22.18 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$3.868 T 17,440,775.79%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$771.09 B 3,476,203.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
HK$2.031 T 9,157,677.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Teva Pharmaceutical Industries
TEVA
HK$270.92 B 1,221,308.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
HK$1.371 T 6,183,679.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$7.473 T 33,692,065.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$858.35 B 3,869,588.03%๐Ÿ‡บ๐Ÿ‡ธ USA